Cargando…

Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist

Cannabinoid receptor 2 agonists and inverse agonists are emerging as new therapeutic options for a spectrum of autoimmune-related disease. Of particular interest, is the ability of CB2 ligands to regulate microglia function in neurodegenerative diseases and traumatic brain injury. We have previously...

Descripción completa

Detalles Bibliográficos
Autores principales:	Presley, Chaela, Abidi, Ammaar, Suryawanshi, Satyendra, Mustafa, Suni, Meibohm, Bernd, Moore, Bob M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506688/ https://www.ncbi.nlm.nih.gov/pubmed/26196013 http://dx.doi.org/10.1002/prp2.159

Ejemplares similares

Optimization of cAMP fluorescence dataset from ACTOne cannabinoid receptor 1 cell line
por: Presley, Chaela S., et al.
Publicado: (2016)

Motor, Visual and Emotional Deficits in Mice after Closed-Head Mild Traumatic Brain Injury Are Alleviated by the Novel CB2 Inverse Agonist SMM-189
por: Reiner, Anton, et al.
Publicado: (2014)

Abnormalities in Dynamic Brain Activity Caused by Mild Traumatic Brain Injury Are Partially Rescued by the Cannabinoid Type-2 Receptor Inverse Agonist SMM-189
por: Liu, Yu, et al.
Publicado: (2017)

Cannabinoid Receptor 2 (CB2) Inverse Agonist SMM-189 Induces Expression of Endogenous CB2 and Protein Kinase A That Differentially Modulates the Immune Response and Suppresses Experimental Colitis
por: Kiran, Sonia, et al.
Publicado: (2022)

Pharmacokinetics and Clinical Pharmacology of Monoclonal Antibodies in Pediatric Patients
por: Temrikar, Zaid H., et al.
Publicado: (2020)

Probing Biology with Small Molecule Microarrays (SMM)
por: Winssinger, Nicolas, et al.
Publicado: (2007)

Transfer of knowledge in international cooperation: the Farmanguinhos – SMM case
por: da Silva, Samuel Araujo Gomes, et al.
Publicado: (2017)

AM281, Cannabinoid Antagonist/Inverse agonist, Ameliorates Scopolamine-Induced Cognitive Deficit
por: Rabbani, Mohammed, et al.
Publicado: (2012)

Psychometric properties of the Stress Mindset Measure (SMM) in the Polish population
por: Mierzejewska-Floreani, Dorota, et al.
Publicado: (2022)

Russian adaptation of Stress Mindset Measure-General (SMM-G)
por: Lebedeva, N., et al.
Publicado: (2022)

Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse Agonists
por: Pandey, Pankaj, et al.
Publicado: (2018)

Using genomics to better define high-risk MGUS/SMM patients
por: Dutta, Ankit K., et al.
Publicado: (2018)

Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
por: Franks, Lirit N., et al.
Publicado: (2016)

2-Arylpropionic Acid Pyrazolamides as Cannabinoid CB2 Receptor Inverse Agonists Endowed with Anti-Inflammatory Properties
por: de Oliveira, Daniela R., et al.
Publicado: (2022)

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
por: Mateos, María-Victoria, et al.
Publicado: (2020)

Reproducibility of isokinetic knee testing using the novel isokinetic SMM iMoment dynamometer
por: Kambič, Tim, et al.
Publicado: (2020)

Dysregulated Humoral and Cellular Response to Sars-Cov-2 Vaccination in Patients with MGUS and SMM
por: Konishi, Yoshinobu, et al.
Publicado: (2022)

A critical review of cannabis in medicine and dentistry: A look back and the path forward
por: Abidi, Ammaar H., et al.
Publicado: (2022)

A Pilot Study into the Effects of the CB1 Cannabinoid Receptor Agonist WIN55,212-2 or the Antagonist/Inverse Agonist AM251 on Sleep in Rats
por: Goonawardena, Anushka V., et al.
Publicado: (2011)

Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability
por: Dutta, Ankit K., et al.
Publicado: (2018)

Assessing the Influence of Child Sexual Behavior on Depression among Black SMM in the Southeastern United States
por: Boyd, Donte Travon, et al.
Publicado: (2022)

Determination of vanillin in different food samples by using SMM/Au@ZIF-67 electrochemical sensor
por: Dehdashtian, Sara, et al.
Publicado: (2023)

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
por: Finlay, David B., et al.
Publicado: (2022)

Cannabinoids: A New Group of Agonists of PPARs
por: Sun, Yan, et al.
Publicado: (2007)

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB(2) receptor
por: Patel, Monica, et al.
Publicado: (2023)

Levels in $^{189}$Ir studied in the decay of $^{189}$Pt
por: Hedin, G, et al.
Publicado: (1972)

Cannabinoids and Dementia: A Review of Clinical and Preclinical Data
por: Walther, Sebastian, et al.
Publicado: (2010)

Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
por: Ladin, Daniel A., et al.
Publicado: (2016)

Cannabinoids as anticancer drugs: current status of preclinical research
por: Hinz, Burkhard, et al.
Publicado: (2022)

Physiological and pharmacokinetic effects of oral 1,3-dimethylamylamine administration in men
por: Schilling, Brian K, et al.
Publicado: (2013)

Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism
por: Gavryushov, Sergei, et al.
Publicado: (2023)

High hopes for cannabinoid agonists in the treatment of rheumatic diseases
por: Staunton, Caroline A, et al.
Publicado: (2014)

Chemical Synthesis, Pharmacokinetic Properties and Biological Effects of JM-00266, a Putative Non-Brain Penetrant Cannabinoid Receptor 1 Inverse Agonist
por: Muller, Tania, et al.
Publicado: (2022)

Cannabinoid Receptor 1 Agonist ACEA and Cannabinoid Receptor 2 Agonist GW833972A Attenuates Cell-Mediated Immunity by Different Biological Mechanisms
por: Takheaw, Nuchjira, et al.
Publicado: (2023)

Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy
por: Tamba, Bogdan Ionel, et al.
Publicado: (2020)

Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
por: Ladin, Daniel A., et al.
Publicado: (2021)

Nuclear spins of $^{186,187,188,189,189m}$Au
por: Ekström, C, et al.
Publicado: (1976)

Elucidation of Inverse Agonist Activity of Bilastine
por: Mizuguchi, Hiroyuki, et al.
Publicado: (2020)

Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method
por: Nielsen, Morten, et al.
Publicado: (2007)

Single Crystal Investigations Unravel the Magnetic Anisotropy of the “Square-In Square” Cr(4)Dy(4) SMM Coordination Cluster
por: Perfetti, Mauro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cglftmsaup31olocel3e15ohuc